Researchers at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types.
Cornell is launching a bold new initiative in artificial intelligence that will expand faculty working both in core areas, as well as the nearly unlimited domains affected by advances in AI.
Pound for pound, the brain consumes vastly more energy than other organs. Now, researchers at Weill Cornell Medicine have found that the process of packaging neurotransmitters may be responsible for this energy drain.
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.
Deborah Estrin, associate dean and the Robert V. Tishman ’37 Professor at Cornell Tech, has been named the 2022 recipient of the prestigious Institute of Electrical and Electronics Engineers (IEEE) John von Neumann Medal.
For physician and epidemiologist Dr. Jay Varma, the COVID-19 pandemic underscores not only the importance of public health, but also the powerful and pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.
A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine researchers.
Students in 20 businesses pitched their ideas to 150 Cornell alumni, investors and friends during the eLab pitch night Nov. 11 at Cornell Tech in New York City.
Antibody protection against harmful forms of fungi in the gut may be disrupted in some patients with Crohn’s disease – a condition caused by chronic inflammation in the bowel – according to a new study by Weill Cornell Medicine investigators.
